

Instance: composition-en-be86a7120b3e7e0f4ee2c7a69bc3ffec
InstanceOf: CompositionUvEpi
Title: "Composition for olanzapine Package Leaflet"
Description:  "Composition for olanzapine Package Leaflet"
Usage: #inline

* identifier.system = "http://ema.europa.eu/identifier"

* identifier.value = "identifier"
* status = #final

* type = https://spor.ema.europa.eu/rmswi/#100000155538
* type.text = "Package Leaflet"

* subject = Reference(mock)
* date = "2022-02-16T13:28:17Z"

 

 // Reference to Organization: MAH
* author = Reference(mah-ema)


* title = "TEST PURPOSES ONLY - olanzapine"
* attester.mode = http://hl7.org/fhir/composition-attestation-mode#official
* attester.time =  "2022-02-16T13:28:17Z"
* language = #en
* category = epicategory-cs#R "Raw"


* section[+].
  * title = "B. Package Leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "B. Package Leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>           </div>"""   


      
* section[=].section[+]
  * title = "Package leaflet: Information for the user"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "Package leaflet: Information for the user"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>           </div>"""   



* section[=].section[+]
  * title = "What is in this leaflet"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "What is in this leaflet"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>What is in this leaflet</p>
<ol>
<li>What Olanzapine Teva is and what it is used for </li>
<li>What you need to know before you take Olanzapine Teva </li>
<li>How to take Olanzapine Teva </li>
<li>Possible side effects </li>
<li>How to store Olanzapine Teva </li>
<li>Contents of the pack and other information </li>
</ol>         </div>"""   
          

* section[=].section[+]
  * title =  "1. What olanzapine is and what it is used for"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text =  "1. What olanzapine is and what it is used for"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Olanzapine Teva contains the active substance olanzapine. Olanzapine Teva belongs to a group of 
medicines called antipsychotics and is used to treat the following conditions:</p>
<ul>
<li>Schizophrenia, a disease with symptoms such as hearing, seeing or sensing things which are not 
there, mistaken beliefs, unusual suspiciousness, and becoming withdrawn. People with this 
disease may also feel depressed, anxious or tense. </li>
<li>Moderate to severe manic episodes, a condition with symptoms of excitement or euphoria. </li>
</ul>
<p>Olanzapine Teva has been shown to prevent recurrence of these symptoms in patients with bipolar 
disorder whose manic episode has responded to olanzapine treatment. </p>         </div>"""   
          

             
* section[=].section[+]
  * title = "2. What you need to know before you take olanzapine"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "2. What you need to know before you take olanzapine"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Do not take Olanzapine Teva 
- if you are allergic to olanzapine or any of the other ingredients of this medicine (listed in section 
6). An allergic reaction may be recognised as a rash, itching, a swollen face, swollen lips or 
shortness of breath. If this has happened to you, tell your doctor. 
- if you have been previously diagnosed with eye problems such as certain kinds of glaucoma 
(increased pressure in the eye). </p>
<p>Warnings and precautions 
Talk to your doctor or pharmacist before taking Olanzapine Teva. 
- The use of Olanzapine Teva in elderly patients with dementia is not recommended as it may 
have serious side effects. 
- Medicines of this type may cause unusual movements mainly of the face or tongue. If this 
happens after you have been given Olanzapine Teva tell your doctor. 
- Very rarely, medicines of this type cause a combination of fever, faster breathing, sweating, 
muscle stiffness and drowsiness or sleepiness. If this happens, contact your doctor at once. 
- Weight gain has been seen in patients taking Olanzapine Teva. You and your doctor should 
check your weight regularly. Consider referral to a dietician or help with a diet plan if 
necessary. 
- High blood sugar and high levels of fat (triglycerides and cholesterol) have been seen in patients 
taking Olanzapine Teva. Your doctor should do blood tests to check blood sugar and certain fat 
levels before you start taking Olanzapine Teva and regularly during treatment. 
- Tell the doctor if you or someone else in your family has a history of blood clots, as medicines 
like these have been associated with the formation of blood clots. </p>
<p>If you suffer from any of the following illnesses tell your doctor as soon as possible:</p>
<ul>
<li>Stroke or  mini  stroke (temporary symptoms of stroke) </li>
<li>Parkinson s disease </li>
<li>Prostate problems </li>
<li>A blocked intestine (Paralytic ileus) </li>
<li>Liver or kidney disease </li>
<li>Blood disorders </li>
<li>Heart disease </li>
<li>Diabetes </li>
<li>Seizures </li>
<li>If you know that you may have salt depletion as a result of prolonged severe diarrhoea and 
vomiting (being sick) or usage of diuretics (water tablets) </li>
</ul>
<p>If you suffer from dementia, you or your carer/relative should tell your doctor if you have ever had a 
stroke or  mini  stroke. </p>
<p>As a routine precaution, if you are over 65 years your blood pressure may be monitored by your 
doctor. </p>
<p>Children and adolescents 
Olanzapine Teva is not for patients who are under 18 years. </p>
<p>Other medicines and Olanzapine Teva 
Tell your doctor or pharmacist if you are taking, have recently taken or might take use any other 
medicines. </p>
<p>Only take other medicines while you are on Olanzapine Teva if your doctor tells you that you can. 
You might feel drowsy if Olanzapine Teva is taken in combination with antidepressants or medicines 
taken for anxiety or to help you sleep (tranquillisers). </p>
<p>In particular, tell your doctor if you are taking:</p>
<ul>
<li>medicines for Parkinson s disease. </li>
<li>carbamazepine (an anti-epileptic and mood stabiliser), fluvoxamine (an antidepressant) or 
ciprofloxacin (an antibiotic) - it may be necessary to change your Olanzapine Teva dose. </li>
</ul>
<p>Olanzapine Teva with alcohol 
Do not drink any alcohol if you have been given Olanzapine Teva as together with alcohol it may 
make you feel drowsy. </p>
<p>Pregnancy and breast-feeding 
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask 
your doctor for advice before taking this medicine. </p>
<p>You should not be given this medicine when breast-feeding, as small amounts of Olanzapine Teva can 
pass into breast milk. 
The following symptoms may occur in newborn babies, of mothers that have used Olanzapine Teva in 
the last trimester (last three months of their pregnancy): shaking, muscle stiffness and/or weakness, 
sleepiness, agitation, breathing problems, and difficulty in feeding. If your baby develops any of these 
symptoms you may need to contact your doctor. </p>
<p>Driving and using machines 
There is a risk of feeling drowsy when you are given Olanzapine Teva. If this happens do not drive or 
operate any tools or machines. Tell your doctor. </p>
<p>Olanzapine Teva contains lactose 
If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor 
before taking this medicinal product. </p>         </div>"""   
                    
* section[=].section[+]
  * title =  "3. How to take olanzapine"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "3. How to take olanzapine"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist 
if you are not sure. </p>
<p>Your doctor will tell you how many Olanzapine Teva tablets to take and how long you should 
continue to take them. The daily dose of Olanzapine Teva is between 5 mg and 20 mg. Consult your 
doctor if your symptoms return but do not stop taking Olanzapine Teva unless your doctor tells you to. </p>
<p>You should take your Olanzapine Teva tablets once a day following the advice of your doctor. Try to 
take your tablets at the same time each day. It does not matter whether you take them with or without 
food. Olanzapine Teva coated tablets are for oral use. You should swallow the Olanzapine Teva tablets 
whole with water. </p>
<p>If you take more Olanzapine Teva than you should 
Patients who have taken more Olanzapine Teva than they should have experienced the following 
symptoms: rapid beating of the heart, agitation/aggressiveness, problems with speech, unusual 
movements (especially of the face or tongue) and reduced level of consciousness. Other symptoms 
may be: acute confusion, seizures (epilepsy), coma, a combination of fever, faster breathing, sweating, 
muscle stiffness and drowsiness or sleepiness, slowing of the breathing rate, aspiration, high blood 
pressure or low blood pressure, abnormal rhythms of the heart. Contact your doctor or hospital straight 
away if you experience any of the above symptoms. Show the doctor your pack of tablets. </p>
<p>If you forget to take Olanzapine Teva 
Take your tablets as soon as you remember. Do not take two doses in one day. </p>
<p>If you stop taking Olanzapine Teva 
Do not stop taking your tablets just because you feel better. It is important that you carry on taking 
Olanzapine Teva for as long as your doctor tells you. 
If you suddenly stop taking Olanzapine Teva, symptoms such as sweating, unable to sleep, tremor, 
anxiety or nausea and vomiting might occur. Your doctor may suggest you to reduce the dose 
gradually before stopping treatment. </p>
<p>If you have any further questions on the use of this medicine, ask your doctor or pharmacist. </p>         </div>"""         

        
* section[=].section[+]
  * title = "4. Possible side effects"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "4. Possible side effects"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Like all medicines, this medicine can cause side effects, although not everybody gets them. </p>
<p>Tell your doctor immediately if you have:</p>
<ul>
<li>unusual movement (a common side effect that may affect up to 1 in 10 people) mainly of the 
face or tongue; </li>
<li>blood clots in the veins (an uncommon side effect that may affect up to 1 in 100 people) 
especially in the legs (symptoms include swelling, pain, and redness in the leg), which may 
travel through blood vessels to the lungs causing chest pain and difficulty in breathing. If you 
notice any of these symptoms seek medical advice immediately; </li>
<li>a combination of fever, faster breathing, sweating, muscle stiffness and drowsiness or sleepiness 
(the frequency of this side effect cannot be estimated from the available data). </li>
</ul>
<p>Very common side effects (may affect more than 1 in 10 people) include weight gain; sleepiness; and 
increases in levels of prolactin in the blood. In the early stages of treatment, some people may feel 
dizzy or faint (with a slow heart rate), especially when getting up from a lying or sitting position. This 
will usually pass on its own but if it does not, tell your doctor. </p>
<p>Common side effects (may affect up to 1 in 10 people) include changes in the levels of some blood 
cells, circulating fats and early in treatment, temporary increases in liver enzymes; increases in the 
level of sugars in the blood and urine; increases in levels of uric acid and creatine phosphokinase in the 
blood; feeling more hungry; dizziness; restlessness; tremor; unusual movements (dyskinesias); 
constipation; dry mouth; rash; loss of strength; extreme tiredness; water retention leading to swelling 
of the hands, ankles or feet; fever; joint pain; and sexual dysfunctions such as decreased libido in 
males and females or erectile dysfunction in males </p>
<p>Uncommon side effects (may affect up to 1 in 100 people) include hypersensitivity (e.g. swelling in 
the mouth and throat, itching, rash); diabetes or the worsening of diabetes, occasionally associated with 
ketoacidosis (ketones in the blood and urine) or coma; seizures, usually associated with a history of 
seizures (epilepsy); muscle stiffness or spasms (including eye movements); restless legs syndrome; 
problems with speech; stuttering; slow heart rate; sensitivity to sunlight; bleeding from the nose; 
abdominal distension; drooling; memory loss or forgetfulness; urinary incontinence; lack of ability to 
urinate; hair loss; absence or decrease in menstrual periods; and changes in breasts in males and 
females such as an abnormal production of breast milk or abnormal growth. </p>
<p>Rare side effects (may affect up to 1 in 1000 people) include lowering of normal body temperature; 
abnormal rhythms of the heart; sudden unexplained death; inflammation of the pancreas causing severe 
stomach pain, fever and sickness; liver disease appearing as yellowing of the skin and white parts of 
the eyes; muscle disease presenting as unexplained aches and pains; and prolonged and/or painful 
erection. </p>
<p>Very rare side effects include serious allergic reactions such as Drug Reaction with Eosinophilia and 
Systemic Symptoms (DRESS). DRESS appears initially as flu like symptoms with a rash on the face 
and then with an extended rash, high temperature, enlarged lymph nodes, increased levels of liver 
enzymes seen in blood tests and an increase in a type of white blood cell (eosinophilia). </p>
<p>While taking olanzapine, elderly patients with dementia may suffer from stroke, pneumonia, urinary 
incontinence, falls, extreme tiredness, visual hallucinations, a rise in body temperature, redness of the 
skin and have trouble walking. Some fatal cases have been reported in this particular group of patients. </p>
<p>In patients with Parkinson's disease Olanzapine Teva may worsen the symptoms. </p>
<p>Reporting of side effects 
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects 
not listed in this leaflet. You can also report side effects directly via the national reporting system 
listed in Appendix V. By reporting side effects you can help provide more information on the safety of 
this medicine. </p>         </div>"""      
        
* section[=].section[+]
  * title = "5. How to store olanzapine"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "5. How to store olanzapine"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>Keep this medicine out of the sight and reach of children. </p>
<p>Do not use this medicine after the expiry date which is stated on the carton after EXP. The expiry date 
refers to the last day of that month. </p>
<p>Do not store above 25 C. Store in the original package in order to protect from light. </p>
<p>Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to 
throw away medicines you no longer use. These measures will help protect the environment. </p>         </div>"""      
        
        
* section[=].section[+]
  * title = "6. Contents of the pack and other information"
  * code = https://spor.ema.europa.eu/rmswi/#100000155538
  * code.text = "6. Contents of the pack and other information"
  * text.status = #additional
  * text.div = """<div xmlns='http://www.w3.org/1999/xhtml'>  <p>What Olanzapine Teva contains </p>
<ul>
<li>The active substance is olanzapine. 
Each Olanzapine Teva 2.5 mg film-coated tablet contains 2.5 mg of the active substance. 
Each Olanzapine Teva 5 mg film-coated tablet contains 5 mg of the active substance. 
Each Olanzapine Teva 7.5 mg film-coated tablet contains 7.5 mg of the active substance. 
Each Olanzapine Teva 10 mg film-coated tablet contains 10 mg of the active substance. 
Each Olanzapine Teva 15 mg film-coated tablet contains 15 mg of the active substance. 
Each Olanzapine Teva 20 mg film-coated tablet contains 20 mg of the active substance. </li>
<li>The other ingredients are: 
Tablet core: lactose monohydrate, hydroxypropylcellulose, crospovidone (type A), silica 
colloidal anhydrous, microcrystalline cellulose, magnesium stearate. 
Tablet coating: hypromellose, polydextrose, glycerol triacetate, macrogol 8000, titanium 
dioxide (E171). In addition, the 15 mg strength contains indigo carmine (E132) and the 20 mg 
strength contains iron oxide red (E172). </li>
</ul>
<p>What Olanzapine Teva looks like and contents of the pack </p>
<p>Olanzapine Teva 2.5 mg film-coated tablet is a white, biconvex, round film-coated tablet, debossed 
 OL 2.5  on one side and plain on the other. 
Olanzapine Teva 5 mg film-coated tablet is a white, biconvex, round film-coated tablet, debossed 
 OL 5  on one side and plain on the other. 
Olanzapine Teva 7.5 mg film-coated tablet is a white, biconvex, round film-coated tablet, debossed 
 OL 7.5  on one side and plain on the other. 
Olanzapine Teva 10 mg film-coated tablet is a white, biconvex, round film-coated tablet, debossed 
 OL 10  on one side and plain on the other. 
Olanzapine Teva 15 mg film-coated tablet is a light blue, biconvex, oval film-coated tablet, debossed 
 OL 15  on one side and plain on the other. 
Olanzapine Teva 20 mg film-coated tablet is a pink, biconvex, oval film-coated tablet, debossed 
 OL 20  on one side and plain on the other. </p>
<p>Olanzapine Teva 2.5 mg film-coated tablets are available in cartons of 28, 30, 35, 56, 70 or 98 film-
coated tablets. 
Olanzapine Teva 5 mg film-coated tablets are available in cartons of 28, 28 x 1, 30, 30 x 1, 35, 35 x 1, 
50, 50 x 1, 56, 56 x 1, 70, 70 x 1, 98 or 98 x 1 film-coated tablets. 
Olanzapine Teva 7.5 mg film-coated tablets are available in cartons of 28, 28 x 1, 30, 30 x 1, 35, 35 x 
1, 56, 56 x 1, 60, 70, 70 x 1, 98 or 98 x 1 film-coated tablets. 
Olanzapine Teva 10 mg film-coated tablets are available in cartons of 7, 7 x 1, 28, 28 x 1, 30, 30 x 1, 
35, 35 x 1, 50, 50 x 1, 56, 56 x 1, 60, 70, 70 x 1, 98 or 98 x1 film-coated tablets. 
Olanzapine Teva 15 mg film-coated tablets are available in cartons of 28, 30, 35, 50, 56, 70 or 98 film-
coated tablets. 
Olanzapine Teva 20 mg film-coated tablets are available in cartons of 28, 30, 35, 56, 70 or 98 film-
coated tablets. </p>
<p>Not all pack sizes may be marketed. </p>
<p>Marketing Authorisation Holder </p>
<p>Teva B.V. 
Swensweg 5 
2031GA Haarlem 
The Netherlands </p>
<p>Manufacturer </p>
<p>Teva Pharmaceutical Works Co. Ltd 
Pallagi  t 4042 Debrecen 
Hungary </p>
<p>For any information about this medicine, please contact the local representative of the Marketing 
Authorisation Holder: </p>
<p>Belgi /Belgique/Belgien 
Teva Pharma Belgium N.V./S.A./AG 
T l/Tel: +32 38207Lietuva 
UAB Teva Baltics 
Tel: +370 52660  </p>
<p>: +359 24899Luxembourg/Luxemburg 
Teva Pharma Belgium N.V./S.A./AG 
Belgique/Belgien 
T l/Tel: +32 38207 esk  republika 
Teva Pharmaceuticals CR, s.r.o. 
Tel: +420 251007Magyarorsz g 
Teva Gy gyszergy r Zrt. 
Tel: +36 12886Danmark 
SanoSwiss UAB 
Litauen 
Tlf: +370 70001Malta 
Teva Pharmaceuticals Ireland 
L-Irlanda 
Tel: +44 2075407Deutschland 
TEVA GmbH 
Tel: +49 73140Nederland 
Teva Nederland B.V. 
Tel: +31 8000228Eesti 
UAB Teva Baltics Eesti filiaal 
Tel: +372 6610Norge 
Teva Norway AS 
Tlf: +47 66775<br />
TEVA HELLAS A.E. 
 : +30 2118805 sterreich 
ratiopharm Arzneimittel Vertriebs-GmbH 
Tel: +43 1970Espa a 
Teva Pharma, S.L.U. 
Tel: +34 913873Polska 
Teva Pharmaceuticals Polska Sp. z o.o. 
Tel: +48 223459France 
Teva Sant<br />
T l: +33 155917Portugal 
Teva Pharma - Produtos Farmac uticos, Lda. 
Tel: +351 214767Hrvatska 
Pliva Hrvatska d.o.o. 
Tel: +385 13720Rom nia 
Teva Pharmaceuticals S.R.L. 
Tel: +40 212306Ireland 
Teva Pharmaceuticals Ireland 
Tel: +44 2075407Slovenija 
Pliva Ljubljana d.o.o. 
Tel: +386 15890 sland 
Teva Pharma Iceland ehf. 
S mi: +354 5503Slovensk  republika 
TEVA Pharmaceuticals Slovakia s.r.o. 
Tel: +421 257267Italia 
Teva Italia S.r.l. 
Tel: +39 028917Suomi/Finland 
Teva Finland Oy 
Puh/Tel: +358 201805<br />
TEVA HELLAS A.E. </p>
<p>: +30 2118805Sverige 
Teva Sweden AB 
Tel: +46 42121Latvija 
UAB Teva Baltics fili le Latvij<br />
Tel: +371 67323United Kingdom (Northern Ireland) 
Teva Pharmaceuticals Ireland 
Ireland 
Tel: +44 2075407This leaflet was last revised in &lt;{MM/YYYY}&gt;&lt;{month YYYY}&gt;. </p>
<p>Detailed information on this medicine is available on the European Medicines Agency web site: </p>         </div>"""      





                      
Instance: bundlepackageleaflet-en-be86a7120b3e7e0f4ee2c7a69bc3ffec
InstanceOf: BundleUvEpi
Title: "ePI document Bundle for olanzapine Package Leaflet for language en"
Description: "ePI document Bundle for olanzapine Package Leaflet for language en"
Usage: #example




* identifier.system = "http://ema.europa.eu/identifier" 
* identifier.value = "None"
* type = #document
* timestamp = "2023-06-27T10:09:22Z"
* language = #en

// Composition
* entry[0].fullUrl = "Composition/composition-en-be86a7120b3e7e0f4ee2c7a69bc3ffec"
* entry[0].resource = composition-en-be86a7120b3e7e0f4ee2c7a69bc3ffec
                      
                      